Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14522940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse Very Long-chain Acyl-CoA Synthetase in X-linked Adrenoleukodystrophy*

  2002cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.

  2002cited by this paper
• Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.

  2002cited by this paper
• APC-dependent suppression of colon carcinogenesis by PPARγ

  2002cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.

  2001cited by this paper
• Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma

  2001cited by this paper
• PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.

  2001cited by this paper
• Therapeutic treatment of DMBA-induced mammary tumors with PPAR ligands.

  2001cited by this paper
• Magnitude of Peroxisome Proliferator-Activated Receptor-γ Activation is Associated With Important and Seemingly Opposite Biological Responses in Breast Cancer Cells

  2001cited by this paper
• Expression of Peroxisome Proliferator-Activated Receptor γ in Renal Cell Carcinoma and Growth Inhibition by Its Agonists

  2001cited by this paper
• Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.

  2001cited by this paper
• Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.

  2001influential reference
• Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma*

  2001cited by this paper
• PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth*

  2001cited by this paper
• Dietary fat, cholesterol and colorectal cancer in a prospective study

  2001cited by this paper
• Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.

  2000cited by this paper
• Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.

  2000cited by this paper
• Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice.

  2000cited by this paper
• Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.

  2000cited by this paper
• Mechanisms Linking Diet and Colorectal Cancer: The Possible Role of Insulin Resistance

  2000cited by this paper
• Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.

  2000cited by this paper
• Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.

  2000cited by this paper
• Adipose Expression of the Phosphoenolpyruvate Carboxykinase Promoter Requires Peroxisome Proliferator-activated Receptor γ and 9-cis-Retinoic Acid Receptor Binding to an Adipocyte-specific Enhancer in Vivo*

  1999cited by this paper
• A New Ligand for the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ), GW7845, Inhibits Rat Mammary Carcinogenesis

  1999cited by this paper
• Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.

  1999cited by this paper
• A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.

  1999cited by this paper
• Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.

  1999cited by this paper
• Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells

  1999cited by this paper
• Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

  1999cited by this paper
• The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

  1999cited by this paper
• Activators of the nuclear receptor PPARgamma enhance colon polyp formation.

  1998cited by this paper
• Differentiation and reversal of malignant changes in colon cancer through PPARγ

  1998cited by this paper
• Activators of the nuclear receptor PPARγ enhance colon polyp formation

  1998cited by this paper
• Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

  1998cited by this paper
• Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice

  1998cited by this paper
• Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.

  1997cited by this paper
• Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs*

  1997cited by this paper
• Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

  1997cited by this paper
• Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.

  1996influential reference
• PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

  1996influential reference
• Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene*

  1996cited by this paper
• The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

  1996cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper
• Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?

  1994cited by this paper
• A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

  1994cited by this paper
• Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper
• Improved enzymatic method for determining free fatty acids in serum, with use of 3-octenoic acid.

  1990cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Changes in serum lipids related to the presence of experimental colon cancer.

  1987cited by this paper
• New water-soluble hydrogen donors for the enzymatic photometric determination of hydrogen peroxide. II. N-ethyl-N-(2-hydroxy-3-sulfopropyl)aniline derivatives.

  1982cited by this paper
• New water-soluble hydrogen donors for the enzymatic spectrophotometric determination of hydrogen peroxide

  1982cited by this paper
• Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

  1973cited by this paper

• The paradigm shift: re-evaluating preclinical animal models for colorectal cancer in the precision medicine era

  2026cites this paper
• Blood metabolic biomarkers and colorectal cancer risk: results from large prospective cohort and Mendelian randomisation analyses

  2025cites this paper
• Reconditioning steatotic liver grafts: Advances in pharmacological defatting approaches for expanding the donor pool.

  2025cites this paper
• Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention

  2024cites this paper
• Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK Biobank cohort.

  2023cites this paper
• The Association between Hypertriglyceridemia and Colorectal Cancer: A Long-Term Community Cohort Study in Taiwan

  2022cites this paper
• Artesunate Inhibits Intestinal Tumorigenesis through Inhibiting Wnt Signaling.

  2020cites this paper
• Relevance of Regulatory T Cells during Colorectal Cancer Development

  2020cites this paper
• Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.

  2019cites this paper
• Abnormality of intestinal cholesterol absorption in ApcMin/+ mice with colon cancer cachexia.

  2019cites this paper
• Human Colorectal Cancer from the Perspective of Mouse Models

  2019cites this paper
• An adenosine derivative (IFC-305) reduced the risk of radiation-induced intestinal toxicity in the treatment of colon cancer by suppressing the methylation of PPAR-r promoter.

  2019cites this paper
• Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery Disease.

  2019cites this paper
• Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.

  2019cites this paper
• Automatisation de la différenciation des cellules souches pluripotentes humaines en cellules de l’épithélium pigmentaire rétinien et modélisation des symptômes rétiniens associés à la mutation d’APC

  2018cites this paper
• Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans

  2018cites this paper
• Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice

  2017cites this paper
• The effect of exposure to thiazolidinediones on the development of head-and-neck cancer in patients with diabetes mellitus

  2017cites this paper
• Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumors

  2017cites this paper
• Citrus Bioactives as Prospective Therapeutic Agents for the Modulation of Colon Cancer

  2017cites this paper
• An insight of consequences of body weight on altered expression of nuclear receptors and interrelation of cyclooxygenase-2 in human colorectal cancers

  2017cites this paper
• Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein

  2017cites this paper
• Clinical Analysis and Correlation between Benign Gastric Polypoid Lesions and Dyslipidaemia

  2016cites this paper
• Clinical Analysis and Correlation between Benign Gastric Polypoid Lesions and

  2016cites this paper
• Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice

  2016cites this paper
• Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis

  2016cites this paper
• Erythrocyte polyamine levels are greater than triglyceride levels as markers of intestinal polyp formation in Min mice

  2016cites this paper
• Extensive metabolic disorders are present in APC(min) tumorigenesis mice.

  2016cites this paper
• Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.

  2016cites this paper
• Status Quo and Prospect of Colorectal Animal Models: Application of Transgenic Technology

  2015cites this paper
• Frequency and Duration Modulate Anticarcinogenic Effects of a Physical Training in the Colon

  2015cites this paper
• The role of peroxisome proliferator activated receptor alpha (PPARα) in the effect of piroxicam on colon cancer

  2015cites this paper
• Effet anti-tumoral de l'acide docosahexaénoïque : implication des microARNs et du TNFalpha

  2015cites this paper
• Candesartan Suppresses Intestinal Carcinogenesis Partly Through Inhibition of Plasminogen Activator Inhibitor1- Expression

  2015cites this paper
• Dietary Administration of Aloe Vera Gel Extract Inhibits Intestinal Polyp Formation in Min Mice Fed a High-Fat Diet

  2015cites this paper
• A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc min/+ mice

  2014cites this paper
• Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.

  2014cites this paper
• Positive and negative effects of glitazones in carcinogenesis: experimental models vs. clinical practice.

  2014cites this paper
• Silibinin alleviates hyperlipidaemia, restores mucin content, modulates TGF-β and fosters apoptosis in experimental rat colon carcinogenesis

  2014cites this paper
• PPARα activation can help prevent and treat non-small cell lung cancer.

  2014cites this paper
• Tumor and Stem Cell Biology PPAR a ActivationCanHelpPrevent andTreatNon – SmallCell Lung Cancer

  2014cites this paper
• Chemoprevention of Colorectal Cancer by Anti‐Inflammatory Agents

  2014cites this paper
• Inhibitory effects of low-dose aloe-emodin on the development of colorectal tumors in min mice.

  2014cites this paper
• Impact des ligands de PPARs, et leurs dérivés, sur les cellules cancéreuses coliques humaines : modifications des statuts redox et glycolytique

  2014cites this paper
• Reduction of intestinal polyp formation in min mice fed a high-fat diet with aloe vera gel extract.

  2013cites this paper
• More than two decades of Apc modeling in rodents.

  2013cites this paper
• Dietary-suppression of hepatic lipogenic enzyme expression in intact male transgenic mice.

  2013cites this paper
• QTL mapping of Apc modifiers in an ApcMin/+ mouse model of spontaneous and irradiation-induced intestinal adenomas.

  2013cites this paper
• Understanding phenotypic variation in rodent models with germline Apc mutations.

  2013cites this paper
• Pioglitazone and cancer: angel or demon?

  2013cites this paper
• Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.

  2013cites this paper
• Metabolic syndrome: a novel high-risk state for colorectal cancer.

  2013cites this paper
• Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments.

  2013cites this paper
• PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

  2012cites this paper
• The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

  2012cites this paper
• Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis

  2012influential citation
• Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.

  2012cites this paper
• Animal models of carcinogenesis in inflamed colorectum: potential use in chemoprevention study.

  2012cites this paper
• Hypolipidemic Activity of Eryngium carlinae on Streptozotocin-Induced Diabetic Rats

  2011cites this paper
• Inhibition of Intestinal Polyp Formation by Pitavastatin, a HMG-CoA Reductase Inhibitor

  2011cites this paper
• High Susceptibility to Zymbal Gland and Intestinal Carcinogenesis in Diabetic Otsuka Long-Evans Tokushima Fatty Rats

  2011cites this paper
• Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice.

  2011cites this paper
• Increase of oxidant‐related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice

  2011cites this paper
• Peroxisome proliferator-activated receptors in endometrial cancer

  2011cites this paper
• BASIC—ALIMENTARY TRACT Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice

  2011cites this paper
• Use of Genetically Engineered Mouse Models in Identification and Validation of Therapeutic Targets for Colon Cancer

  2011cites this paper
• Lipoprotein Lipase as a Candidate Target for Cancer Prevention/Therapy

  2011influential citation
• C57BL/KsJ-db/db-ApcMin/+ Mice Exhibit an Increased Incidence of Intestinal Neoplasms

  2011cites this paper
• Targeting the Wnt pathway in cancer

  2011cites this paper
• Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.

  2010cites this paper
• The nuclear receptor PPARγ individually responds to serotonin‐ and fatty acid‐metabolites

  2010cites this paper
• Peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer

  2010cites this paper
• Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.

  2010cites this paper
• Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia

  2010cites this paper
• Procédés et compositions pour réduire le stress oxydatif

  2010cites this paper
• Alterations Associated with Sulindac-Resistant Pr R on Tumors in Apc Min / + Mice

  2010cites this paper
• Molecular Alterations Associated with Sulindac-Resistant Colon Tumors in ApcMin/+ Mice

  2010cites this paper
• Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/− Mice

  2010cites this paper
• The identification of a novel Paneth cell-associated antigen in a familial adenomatous polyposis mouse model.

  2010cites this paper
• Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.

  2010cites this paper
• APC and its modifiers in colon cancer.

  2009cites this paper
• Overexpression of low‐density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice

  2009cites this paper
• Current Understanding of the Role of PPARγ in Gastrointestinal Cancers

  2009cites this paper
• Inflammatory bowel disease: a model of chronic inflammation-induced cancer.

  2009cites this paper
• Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.

  2009cites this paper
• Title Current understanding of the role of PPAR γ in gastrointestinalcancers

  2009cites this paper
• Risk Factors Intervention

  2009cites this paper
• New synthetic derivatives of triterpenoids in the treatment of cancer

  2009cites this paper
• Chemical and Biological Approaches for Detecting Environmental Causes of Cancer

  2009cites this paper
• Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.

  2008cites this paper
• ReviewArticle Macrophages, PPARs, and Cancer

  2008cites this paper
• Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis.

  2008cites this paper
• ReviewArticle Clinical Use of PPARγ Ligands in Cancer

  2008cites this paper
• Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

  2008influential citation
• The high affinity peroxisome proliferator‐activated receptor‐gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane‐treated mice

  2008cites this paper
• Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells

  2008cites this paper
• Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3

  2008cites this paper
• The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.

  2008cites this paper
• Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator‐activated receptor gamma

  2008cites this paper
• The roles of sPLA 2-IIA ( Pla 2 g 2 a ) in cancer of the small and large intestine

  2008cites this paper